Distance Education Versus Usual Care Qualification in Asthma Care

NCT01595971 | Completed

• 1 other identifier: MED/FNS 774/08
• Study Type: interventional
• Target: 467
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate the effectiveness of multifaceted educational interventions in the care of asthma, conducted remotely over the platform TelessaúdeRS in teams of the Family Health Strategy and the consequent clinical improvement patients.

Conditions

Asthma

Keywords

Asthma; Continuing education; Primary health care

Outcome Measures

Primary Outcomes (1)

• Symptom burden, measured as the number of self-reported asthma symptom days (ASD). ASD is based on 2 week recall.

  The definition of a symptom day includes presence of any of the four types of asthma symptoms: wheeze, cough, night time awakening ou shortness of breath. The results will be collected through the application of standardized questionnaires.

  six months

Secondary Outcomes (3)

• Asthma control

  6 months

• Health care utilization

  6 meses

• Proportion of patients in use inhaled corticosteroids

  6 meses

Study Arms (2)

continuing education

EXPERIMENTAL

RESPIRANET is a multifaceted intervention directed at professionals of the Family Health Teams in the inner cities.Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.

Behavioral: Continuing education

Usual Care

PLACEBO COMPARATOR

usual care

Other: usual care

Interventions

Continuing education BEHAVIORAL

Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.

Also known as: RESPIRANET

continuing education

usual care OTHER

Received the usual care provided

Usual Care

Eligibility Criteria

• Age: 5 Years - 45 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Practice:Participate in the Telessaúde/RS. Minimal staff consisting of a general practitioner, nurse, nurse and community health agents (CHA), ability to give at least ten patients diagnosed with asthma, located in a municipality to make available for free inhaled medication (short-acting bronchodilators and corticosteroids ) for the treatment of asthma and willingness to participate in the study.
• Patients: 5 to 45 years with a diagnosis of asthma made by a physician and register at least one consultation for asthma or an asthma-related hospitalization during the year preceding the beginning of the study.

You may not qualify if:

• Patients with other chronic diseases with pulmonary complications such as tuberculosis, cancer and cystic fibrosis or those with severe mental illness

Sponsors & Collaborators

• Hospital de Clinicas de Porto Alegre: lead
• Federal University of Rio Grande do Sul: collaborator

Study Sites (1)

Hospital de clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Location

Related Links

• Collaborator website

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Erno Harzheim, PHD

  Federal University of Rio Grande do Sul

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 9, 2012
• First Posted: May 10, 2012
• Study Start: August 12, 2010
• Primary Completion: December 16, 2011
• Study Completion: December 16, 2011
• Last Updated: May 15, 2017

Record last verified: 2016-09

Locations

BR (1)